Cannabis for Pain and Headaches: Primer

Area of Science:

• Pharmacology
• Neuroscience
• Pain Management

Background:

• Cannabis has a long history of medicinal and recreational use.
• Recent interest in cannabis compounds for pain relief is growing.
• The discovery of the endocannabinoid system underpins current research.

Purpose of the Study:

• To review the medical applications of marijuana and cannabinoid pharmaceuticals.
• To focus on the efficacy of these compounds for pain and headaches.
• To explore the roles of phytocannabinoids, flavonoids, and terpenes.

Main Methods:

• Literature review of relevant scientific articles.
• Analysis of clinical trials and FDA-approved cannabinoid medications.
• Investigation of both natural and synthetic cannabinoid compounds.

Main Results:

• Synthetic cannabinoids like dronabinol and nabilone are FDA-approved for nausea, vomiting, and wasting.
• Nabiximols, a cannabis extract, is approved for spasticity and pain in Canada and the UK.
• Phytocannabinoids are key to analgesia and anti-inflammatory effects; flavonoids and terpenes are also under investigation.

Conclusions:

• Cannabis-derived compounds, including phytocannabinoids, flavonoids, and terpenes, show significant potential in pain and headache management.
• Approved cannabinoid pharmaceuticals offer treatment options for specific conditions.
• Ongoing research continues to explore the therapeutic benefits of marijuana extracts and their components.